Sone Capital Management’s Colgate-Palmolive CL Stock Holding History

Sone Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-132,053	Closed	-$10.6M	–	109
2025 Q3	$10.6M	Buy	+132,053	New	+$11.3M	0.88%	46
2025 Q2	–	Sell	-57,070	Closed	-$5.35M	–	108
2025 Q1	$5.35M	Buy	57,070 +38,963	+215%	+$3.49M	0.55%	63
2024 Q4	$1.65M	Buy	+18,107	New	+$1.73M	0.21%	103

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sone Capital Management's CL Position: Q4 2025 in Review

Sone Capital Management sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 132,053 shares — an estimated $10.6M sold.

Sone Capital Management first reported a position in CL in Q4 2024 and held it in 3 quarters. The position peaked at $10.6M in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

Sone Capital Management reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
Sone Capital Management sold 132,053 Colgate-Palmolive shares in Q4 2025, an estimated $10.6M.
Sone Capital Management first reported a position in Colgate-Palmolive in Q4 2024 and held it in 3 quarters.
Sone Capital Management's Colgate-Palmolive position peaked at $10.6M in Q3 2025.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Sone Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.